Annovis Bio, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol
ANVS on NYSE
Industry
Pharmaceutical Preparations
Location
101 Lindenwood Drive, Suite 225, Malvern, PA

There are no Buy or Sell transactions made by insiders since 12/25/2023

Annovis Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael B. Hoffman Director, 10%+ Owner $10M Nov 20, 2023
Maria-Luisa Maccecchini President and CEO, Director, 10%+ Owner $6.52M Nov 20, 2023
Mark K. White Director $373K Nov 20, 2023
Reid McCarthy Director $44.6K Nov 20, 2023
Claudine Bruck Director $40.1K Nov 20, 2023
Henry Hagopian III Chief Financial Officer $11.1K Nov 20, 2023
Jeffrey McGroarty Chief Financial Officer Jan 3, 2022

Recent Insider Transactions by Companies or Individuals for Annovis Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.